Skip to main content
Fig. 4 | Cancer Communications

Fig. 4

From: Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study

Fig. 4

Survival curves of patients with different T790M mutations. a Survival curves after TKI failure in 307 patients. b OS curves for patients with different T790M status, as assessed by ARMS and ddPCR. MST median survival time, ARMS amplification refractory mutation system, ddPCR droplet digital PCR

Back to article page

Cancer Communications

ISSN: 2523-3548

Contact us